Kineta Inc (KA): Have you seen this price target? I don&#...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Kineta Inc (KA)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	60
Posts	1519
Boards Moderated	0
Alias Born	07/04/2019

Re: gail post# 8

Friday, 04/19/2024 5:50:00 AM

Friday, April 19, 2024 5:50:00 AM

Have you seen this price target? I don't know if that target is realistic/achievable here?

================

Kineta (KA) Price Target Increased by 25.58% to 13.77
April 17, 2024 — 08:19 pm EDT

The average one-year price target for Kineta (NasdaqCM:KA) has been revised to 13.77 / share. This is an increase of 25.58% from the prior estimate of 10.96 dated March 28, 2024.

The price target is an average of many targets provided by analysts. The latest targets range from a low of 13.64 to a high of 14.18 / share. The average price target represents an increase of 2,770.54% from the latest reported closing price of 0.48 / share.

https://www.nasdaq.com/articles/kineta-ka-price-target-increased-by-25.58-to-13.77

$KA

Don't invest what you can't afford to lose. Always do your own DD. INV4$

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent KA News

Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 10:30:46 AM
Kineta Announces Exclusivity and Right of First Offer Agreement for its VISTA blocking antibody with TuHURA Biosciences • GlobeNewswire Inc. • 07/08/2024 10:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:00:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:03:12 PM
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities • GlobeNewswire Inc. • 05/15/2024 08:01:00 PM
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial • GlobeNewswire Inc. • 04/08/2024 08:01:00 PM
Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/21/2024 08:02:00 PM
KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 VISTA-101 Clinical Trial; Initial Clinical Response Data Reported • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
Kineta Announces Restructuring and Exploration of Strategic Alternatives • GlobeNewswire Inc. • 02/29/2024 01:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:00:14 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:40:31 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:05:45 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:05:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 01:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 01:30:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 11:21:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 10:21:22 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/13/2023 10:28:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 01:30:22 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/03/2023 08:25:46 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/03/2023 08:04:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:02:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:01:09 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 10/20/2023 05:04:10 PM

More KA News

InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM

ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM

Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM

Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow